Atrial Flutter: all 223 studies
Page 3 of 3. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Remote Magnetic Navigation For Cavotricuspid Isthmus AblationCompletedNCT00560872Not applicable
- Maximum Targeted Ablation of Atrial FlutterStatus unknownNCT00491010Phase 4
- A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial FlutterCompletedNCT00476112Phase 2/3
- A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor BlockersCompletedNCT00321945
- A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial ArrhythmiasTerminatedNCT00321204
- EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)CompletedNCT00259428Phase 3
- American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus RhythmCompletedNCT00259376Phase 3
- Amiodarone to Prevent Post-Operative ArrhythmiasCompletedNCT00251706Phase 3
- Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECGCompletedNCT00251121Not applicable
- Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial FibrillationTerminatedNCT00243802
- Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/FlutterCompletedNCT00233441Phase 2/3
- Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttErCompletedNCT00232310Phase 2
- Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial ArrhythmiaCompletedNCT00232232Phase 4
- Catheter Ablation as the First Line Therapy for Typical Atrial FlutterTerminatedNCT00213408Phase 4
- Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial FlutterStatus unknownNCT00196170Phase 4
- Safety and Efficacy Study of RENEWAL 4 AVTCompletedNCT00180336Phase 2/3
- Markers of Oxidative Stress Present in Blood in Patients With Atrial FibrillationCompletedNCT00142194
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126074Phase 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male SubjectsCompletedNCT00126061Phase 3
- Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsCompletedNCT00126022Phase 3
- Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart SurgeryCompletedNCT00125320Phase 3
- Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial FlutterCompletedNCT00115791Phase 3
- Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial FlutterCompletedNCT00113178Phase 3